Search research articles
Contact Us
Filters
Showing results (181-190 of 377) with videos related to
Page
of 38
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 20, 2006
Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: an update
Manfred Kaufmann, Gabriel N Hortobagyi, Aron Goldhirsch, et al.
Geburtshilfe Und Frauenheilkunde
|
June 25, 2021
Update Breast Cancer 2021 Part 3 - Current Developments in the Treatment of Early Breast Cancer: Review and Assessment of Specialised Treatment Scenarios by an International Expert Panel
Tanja N Fehm, Elmar Stickeler, Peter A Fasching, et al.
NPJ Breast Cancer
|
April 7, 2023
Identifying breast cancer patients at risk of relapse despite pathological complete response after neoadjuvant therapy
Jens Huober, Marion van Mackelenbergh, Andreas Schneeweiss, et al.
Annals of Surgical Oncology
|
February 25, 2026
Surgical Outcomes After Neoadjuvant Pembrolizumab Plus Chemotherapy for Triple-Negative Breast Cancer: Results from the Randomized, Placebo-Controlled Phase 3 KEYNOTE-522 Study
Sherko Kuemmel, Peter A Fasching, Peter Schmid, et al.
Annals of Surgical Oncology
|
March 12, 2026
ASO Visual Abstract: Surgical Outcomes After Neoadjuvant Pembrolizumab Plus Chemotherapy for Triple-Negative Breast Cancer-Results from the Randomized, Placebo-Controlled Phase 3 KEYNOTE-522 Study
Sherko Kuemmel, Peter A Fasching, Peter Schmid, et al.
JAMA Oncology
|
February 4, 2021
Efficacy of Endocrine Therapy for the Treatment of Breast Cancer in Men: Results from the MALE Phase 2 Randomized Clinical Trial
Mattea Reinisch, Sabine Seiler, Tanja Hauzenberger, et al.
Breast Cancer Research and Treatment
|
February 14, 2015
Impact of body mass index on neoadjuvant treatment outcome: a pooled analysis of eight prospective neoadjuvant breast cancer trials
Caterina Fontanella, Bianca Lederer, Stephan Gade, et al.
Geburtshilfe Und Frauenheilkunde
|
August 24, 2023
Systemic Therapy of Premenopausal Patients with Early Stage Hormone Receptor-Positive, HER2-Negative Breast Cancer - Controversies and Standards in Healthcare
Volkmar Müller, Peter A Fasching, Naiba Nabieva, et al.
Geburtshilfe Und Frauenheilkunde
|
August 4, 2017
Initial Treatment of Patients with Primary Breast Cancer: Evidence, Controversies, Consensus: Spectrum of Opinion of German Specialists at the 15th International St. Gallen Breast Cancer Conference (Vienna 2017)
Michael Untch, Jens Huober, Christian Jackisch, et al.
British Journal of Cancer
|
September 1, 2022
Outcomes of patients with small and node-negative HER2-positive early breast cancer treated with adjuvant chemotherapy and anti-HER2 therapy-a sub-analysis of the ALTTO study
Guilherme Nader-Marta, Véronique Debien, Daniel Eiger, et al.
Page
of 38
Search research articles
Search
Showing results (181-190 of 377) with videos related to
Sort By:
Page
of 38
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 20, 2006
Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: an update
Manfred Kaufmann, Gabriel N Hortobagyi, Aron Goldhirsch, et al.
Geburtshilfe Und Frauenheilkunde
|
June 25, 2021
Update Breast Cancer 2021 Part 3 - Current Developments in the Treatment of Early Breast Cancer: Review and Assessment of Specialised Treatment Scenarios by an International Expert Panel
Tanja N Fehm, Elmar Stickeler, Peter A Fasching, et al.
NPJ Breast Cancer
|
April 7, 2023
Identifying breast cancer patients at risk of relapse despite pathological complete response after neoadjuvant therapy
Jens Huober, Marion van Mackelenbergh, Andreas Schneeweiss, et al.
Annals of Surgical Oncology
|
February 25, 2026
Surgical Outcomes After Neoadjuvant Pembrolizumab Plus Chemotherapy for Triple-Negative Breast Cancer: Results from the Randomized, Placebo-Controlled Phase 3 KEYNOTE-522 Study
Sherko Kuemmel, Peter A Fasching, Peter Schmid, et al.
Annals of Surgical Oncology
|
March 12, 2026
ASO Visual Abstract: Surgical Outcomes After Neoadjuvant Pembrolizumab Plus Chemotherapy for Triple-Negative Breast Cancer-Results from the Randomized, Placebo-Controlled Phase 3 KEYNOTE-522 Study
Sherko Kuemmel, Peter A Fasching, Peter Schmid, et al.
JAMA Oncology
|
February 4, 2021
Efficacy of Endocrine Therapy for the Treatment of Breast Cancer in Men: Results from the MALE Phase 2 Randomized Clinical Trial
Mattea Reinisch, Sabine Seiler, Tanja Hauzenberger, et al.
Breast Cancer Research and Treatment
|
February 14, 2015
Impact of body mass index on neoadjuvant treatment outcome: a pooled analysis of eight prospective neoadjuvant breast cancer trials
Caterina Fontanella, Bianca Lederer, Stephan Gade, et al.
Geburtshilfe Und Frauenheilkunde
|
August 24, 2023
Systemic Therapy of Premenopausal Patients with Early Stage Hormone Receptor-Positive, HER2-Negative Breast Cancer - Controversies and Standards in Healthcare
Volkmar Müller, Peter A Fasching, Naiba Nabieva, et al.
Geburtshilfe Und Frauenheilkunde
|
August 4, 2017
Initial Treatment of Patients with Primary Breast Cancer: Evidence, Controversies, Consensus: Spectrum of Opinion of German Specialists at the 15th International St. Gallen Breast Cancer Conference (Vienna 2017)
Michael Untch, Jens Huober, Christian Jackisch, et al.
British Journal of Cancer
|
September 1, 2022
Outcomes of patients with small and node-negative HER2-positive early breast cancer treated with adjuvant chemotherapy and anti-HER2 therapy-a sub-analysis of the ALTTO study
Guilherme Nader-Marta, Véronique Debien, Daniel Eiger, et al.
Page
of 38